Bingxia Li
YOU?
Author Swipe
View article: LPS‑mediated adaptation accelerates ecto‑MSCs differentiation into osteoblasts
LPS‑mediated adaptation accelerates ecto‑MSCs differentiation into osteoblasts Open
Addressing the repair and regeneration of large bone defects poses significant challenges in bone tissue engineering. Despite the abundant evidence demonstrating the positive role of MSCs in osteogenesis, their limited osteogenic different…
View article: A single-cell panorama of human umbilical cord blood-derived expanded memory-like natural killer cells
A single-cell panorama of human umbilical cord blood-derived expanded memory-like natural killer cells Open
This work was supported by grants from the National Natural Science Foundation of China (No. 81800150 to Bo Cai, No. 81670110 to Kaixun Hu, and No. 31500732 to Yi Wang), Translational Research Grant of NCRCH (No. 2020ZKZB02 to Mei Guo), th…
View article: Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island
Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island Open
Objective The sequencing panel composed of 61 target genes was used to explore the related mutation genes of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis (OSF) cancerization, so as to provide a theoretical basis for the …
View article: Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia
Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia Open
Background: Immunotherapies such as adoptive immune cell infusion and immune-modulating agents are widely used for cancer treatment, and the concomitant symptoms, including cytokine release syndrome (CRS) or immune-related adverse events (…
View article: Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia
Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia Open
Post-remission strategies for patients with acute lymphoblastic leukemia (ALL) are limited to the multiagent chemotherapy and allogeneic stem cell transplant (allo-SCT), and cellular therapies are seldom involved. Although chemotherapy com…
View article: An FGFR1-Binding Peptide Modified Liposome for siRNA Delivery in Lung Cancer
An FGFR1-Binding Peptide Modified Liposome for siRNA Delivery in Lung Cancer Open
Liposome modification by targeting ligands has been used to mediate specific interactions and drug delivery to target cells. In this study, a new peptide ligand, CP7, was found to be able to effectively bind to FGFR1 through reverse molecu…
View article: Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia. Open
Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) have poor prognosis, and the efficacy of chemotherapy plus tyrosine kinase inhibitors (TKIs) followed by mismatched donor stem cell infusion (microtransp…
View article: Mannose‐Modified Multi‐Walled Carbon Nanotubes as a Delivery Nanovector Optimizing the Antigen Presentation of Dendritic Cells
Mannose‐Modified Multi‐Walled Carbon Nanotubes as a Delivery Nanovector Optimizing the Antigen Presentation of Dendritic Cells Open
Dendritic cells (DCs) based cancer immunotherapy is largely dependent on adequate antigen delivery and efficient induction of DCs maturation to produce sufficient antigen presentation and ultimately lead to substantial activation of tumor‐…
View article: Physiologically stable F127-GO supramolecular hydrogel with sustained drug release characteristic for chemotherapy and photothermal therapy
Physiologically stable F127-GO supramolecular hydrogel with sustained drug release characteristic for chemotherapy and photothermal therapy Open
The F127-GO-DOX supramolecular hydrogel system with sustained drug release characteristic for chemotherapy and photothermal therapy.